LPL Financial (LPLA): Assessing Valuation After Major First Horizon Asset Transition Expands Institutional Platform

LPL Financial Holdings (LPLA) just hit a major milestone, and investors are paying attention. The company announced that First Horizon Bank has completed a significant transition of its broker-dealer and investment advisory services to LPL’s institutional platform, representing a transfer of about $12 billion in assets in August. This partnership was first flagged earlier in the year, but the recent onboarding confirms LPL’s ability to land large institutional clients and successfully integrate their business. Looking at the broader picture, LPL hasn’t been immune to market swings. The share price has dipped over the month and past three months, softening some of the momentum built earlier this year. Still, with a total one-year return in the high double digits, this growth story remains intact over the longer term. The First Horizon transition, following previous platform expansions, signals LPL’s continued strength in capturing new business in a competitive industry. The latest pullback raises a timely valuation debate about whether this is a rare entry point for LPL shares or if investors have already factored in the potential upside from such growth wins.
Advertisement

Most Popular Narrative: 24.5% Undervalued

The most widely followed narrative positions LPL Financial Holdings as significantly undervalued, estimating substantial upside if growth catalysts play out as expected.

Strategic investments in proprietary technology platforms and automation are driving ongoing operational efficiencies, leading to improved operating leverage and sustainable gains in net margins. This is reflected in enhanced margin guidance and cost discipline initiatives that are ahead of schedule.

What is fueling such a bullish price target? The narrative points to bold growth assumptions and cost-saving breakthroughs that could reset profit expectations higher. Want to understand how those projections compare and what is really driving that deep discount to the current market price? Explore the full story behind these numbers.

Result: Fair Value of $441.25 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, risks such as margin pressure from fee compression and earnings volatility related to interest rates could challenge the optimistic case for LPL’s valuation.

Find out about the key risks to this LPL Financial Holdings narrative.

Another View: Discounted Cash Flow Perspective

Our DCF model offers a different perspective and suggests the stock also trades below its intrinsic value. While this supports the initial case, the DCF is based on long-term forecasts. Could reality unfold differently?

Look into how the SWS DCF model arrives at its fair value.

LPLA Discounted Cash Flow as at Sep 2025
LPLA Discounted Cash Flow as at Sep 2025

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out LPL Financial Holdings for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own LPL Financial Holdings Narrative

If you think there is more to LPL Financial Holdings’ story or want to run your own numbers, it takes just a few minutes to build and test your own outlook. Do it your way.

A great starting point for your LPL Financial Holdings research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.

Looking for More Smart Investment Opportunities?

Don’t let your strategy stop here. Make your next move with confidence by tapping into innovative opportunities other investors are already watching. Choose what fits your style and goals.

  • Spot tomorrow’s tech giants early by browsing breakthrough AI penny stocks revolutionizing industries with artificial intelligence advancements.
  • Unlock income potential with steady earners, and see which companies deliver consistent payouts through our handpicked list of dividend stocks with yields > 3%.
  • Uncover hidden gems trading below their worth, using real-time cash flow analysis in our expertly curated undervalued stocks based on cash flows.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Kshitija Bhandaru

Kshitija Bhandaru

Kshitija (or Keisha) Bhandaru is an Equity Analyst at Simply Wall St and has over 6 years of experience in the finance industry and describes herself as a lifelong learner driven by her intellectual curiosity. She previously worked with Market Realist for 5 years as an Equity Analyst.

About NasdaqGS:LPLA

LPL Financial Holdings

Provides an integrated platform of brokerage and investment advisory services to independent financial advisors and financial advisors at institutions in the United States.

Reasonable growth potential and fair value.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
47 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
67 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
81 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
185 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
71 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0